Federation des caisses Desjardins du Quebec’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-700
Closed -$7.3K – 2225
2020
Q2
$7.3K Sell
700
-43,956
-98% -$455K ﹤0.01% 1734
2020
Q1
$381K Buy
+44,656
New +$434K 0.01% 697
2018
Q3
– Sell
-200
Closed -$11.8K – 2179
2018
Q2
$11.8K Hold
200
– – ﹤0.01% 1710
2018
Q1
$13.6K Buy
+200
New +$15K ﹤0.01% 1638

Other funds holding PBYI

Federation des caisses Desjardins du Quebec's PBYI Position: Q3 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Puma Biotechnology (PBYI) in Q3 2020, closing a stake of 700 shares — an estimated $7.3K sold.

Federation des caisses Desjardins du Quebec first reported a position in PBYI in Q1 2018 and held it in 4 quarters. The position peaked at $381K in Q1 2020. 128 funds tracked by Wall St. Rank hold PBYI as of Q3 2020.

  • Federation des caisses Desjardins du Quebec reported no remaining Puma Biotechnology position as of Q3 2020 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 700 Puma Biotechnology shares in Q3 2020, an estimated $7.3K.
  • Federation des caisses Desjardins du Quebec first reported a position in Puma Biotechnology in Q1 2018 and held it in 4 quarters.
  • Federation des caisses Desjardins du Quebec's Puma Biotechnology position peaked at $381K in Q1 2020.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2020, filed 30 Aug 2024.